Cargando…

Correction to: SHP2 mutations induce precocious gliogenesis of Noonan syndrome-derived iPSCs during neural development in vitro

Detalles Bibliográficos
Autores principales:	Ju, Younghee, Park, Jun Sung, Kim, Daejeong, Kim, Bumsoo, Lee, Jeong Ho, Nam, Yoonkey, Yoo, Han-Wook, Lee, Beom Hee, Han, Yong-Mahn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364466/ https://www.ncbi.nlm.nih.gov/pubmed/32669122 http://dx.doi.org/10.1186/s13287-020-01775-8

Ejemplares similares

SHP2 mutations induce precocious gliogenesis of Noonan syndrome-derived iPSCs during neural development in vitro
por: Ju, Younghee, et al.
Publicado: (2020)

Aberrant Cortical Layer Development of Brain Organoids Derived from Noonan Syndrome-iPSCs
por: Kim, Bumsoo, et al.
Publicado: (2022)

Dysregulated ECM remodeling proteins lead to aberrant osteogenesis of Costello syndrome iPSCs
por: Choi, Jong Bin, et al.
Publicado: (2021)

Emerging Neural Stimulation Technologies for Bladder Dysfunctions
por: Lee, Jee Woong, et al.
Publicado: (2015)

Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
por: Kwon, Yoo-Wook, et al.
Publicado: (2021)

Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome
por: Lee, Yeonmi, et al.
Publicado: (2023)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

Growth hormone therapy in patients with Noonan syndrome
por: Seo, Go Hun, et al.
Publicado: (2018)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2
por: Toto, Angelo, et al.
Publicado: (2020)

Disruption of polyubiquitin gene Ubb causes dysregulation of neural stem cell differentiation with premature gliogenesis
por: Ryu, Han-Wook, et al.
Publicado: (2014)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
por: Jeong, Insook, et al.
Publicado: (2016)

Naive-like ESRRB(+) iPSCs with the Capacity for Rapid Neural Differentiation
por: Kisa, Fumihiko, et al.
Publicado: (2017)

Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 Gene mutation
por: Kim, Yoo-Mi, et al.
Publicado: (2013)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

Human neural progenitors derived from integration-free iPSCs for SCI therapy
por: Liu, Ying, et al.
Publicado: (2017)

Adult Neurogenesis and Gliogenesis: Possible Mechanisms for Neurorestoration
por: Rusznák, Zoltán, et al.
Publicado: (2016)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome
por: Jo, Kyo Jin, et al.
Publicado: (2019)

Thoracic Rat Spinal Cord Contusion Injury Induces Remote Spinal Gliogenesis but Not Neurogenesis or Gliogenesis in the Brain
por: Franz, Steffen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0bgg86fu4lq6mjum0759slsdis